Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Tilray Brands, Inc.NASDAQ: TLRY

Gross Profit · Q3 FY2026 · quarter ended Feb 2026

Gross profit declines year over year

Q3 FY2026 gross profit of $75.02M fell 0.1% year over year, ahead of the -7.5% change in trailing-twelve-month gross profit. Sequentially, it fell 6.6% from the prior quarter. Over 3 fiscal years it compounded at +30.9% a year.

Context

  • Gross profit amounted to 29.3% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -0.1% holds above the trailing-twelve-month pace of -7.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$75.02M-6.6% QoQ
Last fiscal yearMay 2025
$330.11M+8.5% YoY
LTMFeb 2026
$327.08M-7.5% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.1%——
1 year+8.5%——
3-year CAGR+30.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
330.11M USD
Year-over-year change
+8.5%
4-year CAGR
+22.0%

Gross Profit vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -7.5% is the lowest of 3, against a peer median of -1.4%.
  • Gross profit amounts to 27.7% of revenue for TLRY, versus a peer median of 41.9%.
TLRY Competitors
Gross Profit for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRYTilray Brands, Inc.LTM Feb 2026$327.08M USD-7.5%+30.9%27.7%
SNDLSNDL Inc.LTM Mar 2026CA$254.82M CAD+3.3%+22.6%27.2%
ACBAurora Cannabis Inc.LTM Mar 2026CA$176.08M CAD-6.1%+4.2%56.6%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —-1.4%+13.4%41.9%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue619.67M792.12M844.72M1.07B1.13B
Cost of Revenue470.9M644.86M646.77M770.66M796.88M
Gross Profit148.77M147.26M197.95M304.33M330.11M
Gross Margin24.0%18.6%23.4%28.3%29.3%
Research & Development1M1.91M918.64K865.23K389.7K
Selling, General & Admin188.03M233.38M311.13M341.63M356.06M
Operating Expenses308.4M916.72M2.04B542.43M3.46B
Depreciation & Amortization81.92M194.88M175.31M172.93M183.17M
EBITDA(297.41M)(310.61M)(1.72B)(99.25M)(2.92B)
EBITDA Margin-48.0%-39.2%-203.1%-9.2%-259.0%
Operating Income(159.63M)(769.46M)(1.84B)(238.1M)(3.13B)
Operating Margin-25.8%-97.1%-218.4%-22.1%-277.9%
Interest Income3.53M14.79M44.48M17.48M15.61M
Interest Expense37.32M50.02M62.79M67.13M56.71M
Other Income / Expenses(257.02M)213.96M(108.43M)(101.2M)(26.99M)
Income Before Tax(416.65M)(555.51M)(1.95B)(339.31M)(3.16B)
Pre-Tax Margin-67.2%-70.1%-231.2%-31.6%-280.3%
Income Tax Expense(10.84M)(8.25M)(9.67M)(36.27M)(166.06M)
Net Income(443.75M)(601.05M)(1.96B)(333.8M)(3B)
Net Margin-71.6%-75.9%-231.6%-31.1%-266.3%
EPS (Basic)(13.61)(9.94)(31.70)(4.50)(33.80)
EPS (Diluted)(13.61)(9.94)(31.70)(4.50)(33.80)
Weighted Avg Shares26.95M48.12M61.8M74.26M89.03M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M89.03M

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.